Liwasag, Luzviminda .
HRN: 25-86-17 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2024
AMPICILLIN 1GM (VIAL)
10/27/2024
10/29/2024
IV
2 G
Q6
PROM
Waiting Final Action